Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Summary

The purpose of this study is to evaluate the safety and efficacy of icotinib in combination with whole brain radiotherapy for NSCLC patients with brain metastases. The primary endpoint is objective response rate of intracranial lesions.

Timeline

Start

2013-06

Primary completion

2016-09

Completion

2016-12

Drugs

Indications